Background: Charcot's Neuroarthropathy (Charcot foot) is a debilitating and destructive disorder resulting from neurological changes in the foot. Whilst the majority of cases are painless, as a result of disruption to sensory function, a common outcome is severe deformity that impacts considerably on foot function. The purpose of this study was to develop and validate a radiological severity scale to quantify resultant damage from acute mid foot Charcot's. This in turn can be used to evaluate clinical outcomes related to different degrees of offloading.Methods: A four round Delphi process was used to develop five tool items. Level of consensus and agreement was set at 80%. Inter‐rater and intra‐rater reliability was evaluated using 3 raters and 24 plain x‐rays of chronic mid‐foot Charcot's. Strength of agreement of individual items and overall scores was calculated using weighted Kappa coefficients (S.E). Cronbach's α was used to determine internal consistency. Floor (> 15% score 0) and ceiling (> 15% score 11) effects were examined at each time point. Spearman's correlation coefficient was used to assess construct validity using Mobility and Usual Activity scores taken from the EQ‐5D‐5 L.Results: Twenty two patients participated. The five item severity scale demonstrated a Cronbach's α of 0.91. Intra‐rater Kappa coefficients (SE) for total scores ranged from 0.84 (0.20) to 0.86 (0.20). Inter rater coefficients (SE) ranged from 0.72 (0.14) to 0.83 (0.14). Distribution was normal and no floor or ceiling effects were identified.Conclusion/interpretation: This study suggests it may be possible to quantify resultant damage from mid foot Charcot's. Given the physical and emotional impacts from long periods of complete immobilisation defining a minimum standard would be an important development in the management of Charcot foot.
17 November 2024 in Journal of Foot and Ankle Research
Introduction: Charcot neuroarthropathy (CN) can result in fractures and dislocations of the foot and ankle in individuals with diabetes and neuropathy, leading to ulceration, amputation and a poor quality of life. Additional episodes of acute CN can lead to extended periods of physical and psychosocial distress. The aim of this scoping review was to identify and synthesise the evidence relating to factors associated with the development of recurrent and contralateral Charcot neuroarthropathy (CN) in individuals with diabetes.Methods: A systematic search of four electronic databases was conducted from inception to February 06, 2023. All relevant study designs, except single case studies, that had been published in full in peer‐reviewed journals were included. Studies were excluded if they were not published in English and did not provide data on individuals with diabetes.Results: The search identified two studies that investigated factors associated with the development of recurrent CN, but none that related to the development of contralateral CN. Ten factors were investigated for association with recurrent CN development: age, body mass index, diabetes type and duration, glycated haemoglobin, anatomical site affected, duration of offloading applied to treat the primary CN episode, use of pharmacological intervention, severity of neuropathy, and skin temperature. However, no significant associations were reported.Conclusions: There is an alarming lack of evidence‐based findings in this research area to guide practice. Clearly, more research in the form of rigorous prospective studies is urgently required to identify risk factors for the development of recurrent and contralateral CN in individuals with diabetes.
2 February 2026 in Journal of Foot and Ankle Research
Background: To conduct a bibliographic analysis of English language foot and ankle research pertaining to rheumatology published by Australian authors. Methods: The Scopus database search was conducted to identify all Australian rheumatology articles published by podiatric authors in English from 1970 to 2024. Bibliometric analysis was performed using an open‐source tool based on the R language. Citations, journals, authors, institutions and countries were described. Publications were manually categorised according to research type, level of evidence and funding source. Results: The search strategy yielded 89 eligible articles, which received a total of 2438 citations and were published by 200 authors. The most frequent journals were Arthritis Care & Research and Osteoarthritis and Cartilage each with 9 articles or 10% of total publications. The most published institution was La Trobe University (affiliation of 151 authors). Most of the Australian rheumatology articles focused on the evaluation of treatments and therapeutic interventions ( n = 35; 39%) and 11 articles (12%) provided Level I evidence. Forty‐two publications (47%) were supported by Category 1 funding, however, 29 (33%) reported no research funding. Conclusion: Rheumatology represents just 5% of Australian podiatry research. Despite this, it attracts high citation rates relative to number of publications and is well supported by Category 1 funding in comparison to other research fields. Funding sources outside of competitive Category 1 grants appear to be limited however, and research scope is narrow with a high number of evaluative studies conducted. Rheumatology research would benefit from an increase in available funding sources and a broader research scope that informs disease prevention and evidence‐based clinical care.
29 January 2026 in Journal of Foot and Ankle Research
Introduction: Charcot neuroarthropathy (CN) can result in severe destruction of the foot and the ankle. Additional episodes of acute CN in the same or contralateral foot cause additional burden. This study aimed to explore Australian high‐risk foot podiatrists' understanding of recurrent and contralateral CN in individuals with diabetes. Methods: Semi‐structured online interviews were conducted. Interviews were audio‐recorded and transcribed. Thematic content analysis was used. Results: Five themes were identified in relation to recurrent and contralateral CN—two were related to potential risk factors: patients and systems and addressing clinical complexity , two were related to preventive interventions: protection as prevention and knowledge and surveillance and one was related to barriers to implementing preventive interventions: financial and personal endurance . The most reported risk factors were reduced adherence to management and lack of knowledge. Many preventive interventions were reported, but there was a lack of consensus on standardised care, and due to significant barriers, these interventions were not frequently used. Conclusion: This study found that participants perceived a range of potential risk factors for recurrent and contralateral CN. They also reported a variety of preventive interventions; however, due to associated barriers, these were not frequently applied. Further rigorous research is needed to develop evidence‐based guidelines.
11 February 2026 in Journal of Foot and Ankle Research
Introduction: Falls are a major concern for older women and can result in significant injury. Footwear has been shown to improve or impair balance performance in older women, contingent upon footwear design features. Balance‐enhancing shoes may reduce the risk of falling but their acceptability is unknown. Acceptability is important because it influences the level of adherence to the intervention. The aim of this trial protocol is to describe the methodology of a randomised crossover trial to compare the acceptability of balance‐enhancing outdoor shoes versus minimalist outdoor shoes in older women and compare the effects of these two interventions on the perceived risk of falling and balance performance. Methods: The trial will use a randomised two‐period crossover trial methodology. We will recruit 44 community‐dwelling women aged 65 years or older who will be randomised to receive a pair of minimalist shoes (Basic Lace Up Canvas Shoes, Kmart Australia Ltd, Mulgrave, Australia) or a pair of balance‐enhancing shoes (Balla Balance Leather Lace Up Boots, Ziera Australia, Abbotsford, Australia), which encompass key features known to be beneficial for balance such as adequate fixation, a firm heel counter, high heel collar, firm midsole and textured insole. The order of the interventions will be randomised. Cross‐over to the second shoe condition will occur at 6 weeks. Outcome measures will be collected at baseline, six and 12 weeks; the primary endpoint for assessing footwear acceptability for each shoe condition will be 6 weeks. The primary outcome measure will be footwear acceptability, evaluated using a modified version of the Monitor Orthopaedic Shoes Questionnaire. Secondary outcome measures include perceived risk of falling (the Falls Efficacy Scale International) and balance performance (upper body stability when walking, using the GyKo wearable sensor). Discussion: This trial will evaluate the acceptability, perceived risk of falling and balance performance of minimalist shoes versus balance‐enhancing shoes. The findings will provide much‐needed evidence as to the acceptability of these two shoe types in older women. Such information may support footwear design to increase balance performance and reduce risk of falling. Trial Registration: Australian and New Zealand Clinical Trial Registry (ACTRN12624001496505)